A Pharmacokinetic Study of TQB3101 in Chinese Healthy Subjects

Pharmacokinetic Study Clinical Trial

Official title:
A Single Center, Phase I, Open-Label, Randomized, Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of TQB3101 in Healthy Subjects

Status Completed

Clinical Trial Summary

Evaluate the effect of food on the pharmacokinetics of TQB3101 in healthy subjects.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Pharmacokinetic Study

Clinical Trial Details

NCT number	NCT04804904
Study type	Interventional
Source	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Contact
Status	Completed
Phase	Phase 1
Start date	May 20, 2021
Completion date	July 3, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01714856` - Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fed Conditions	Phase 1
Completed	`NCT01717235` - Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fasting Conditions	Phase 1
Completed	`NCT01712568` - Two Way Cross Over BE Fasting Pilot Study of Ropinirole Hydrochloride CR 2mg Tablets	Phase 1
Completed	`NCT04613999` - A Study of Ralinepag in Healthy Chinese Adult Subjects	Phase 1
Completed	`NCT05609929` - Study the Effect of Omeprazole on AB-106 Pharmacokinetics	Phase 1
Recruiting	`NCT04788810` - Toxicokinetic Study of Dichlorobisphenol A After an Oral or Dermal Single Dose in Healthy Volunteer.	N/A